Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood
Authors:
- A RahimARA Rahim
- E M MackieEME M Mackie
- O B EdenOEO B Eden
- S M ShaletSSS M Shalet
- 1 June 1998
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 48 (6) , 777-783
Abstract
Growth hormone status was assessed in a cohort of 32 (16 male) adults who had received cranial irradiation (XRT) in childhood as part of their treatment for acute lymphoblastic leukaemia (ALL) and compared with 35 age matched young adults (18 male). Height and weight were measured in all subjects and the heights of the patients at XRT were obtained from their case notes. Each patient and control underwent two provocative tests of growth hormone (GH) secretion using insulin (0.2 IU/kg body weight) and arginine (20 g/m2). Basal serum insulin like growth factor-1 (IGF-1) and IGFBP-3 (binding protein-3) concen_trations were also measured. The patient group had a significantly lower peak GH response to both provocative tests (P < 0.01), and lower IGF-1 and IGFBP-3 levels compared with the normal controls (P < 0.01). Nine of the patient group were severely GH deficient (peak GH response <9 mU/l to both provocative agents) and a further 12 patients were GH insufficient (peak GH response 9 mU/l). Overall a significant median change in height from XRT to final height of −0.5 SDS was found which was even greater in the severely GH deficient group (median change in height of −2.1 SDS). These data suggest that a significant proportion of adults treated with cranial XRT in childhood with irradiation doses between 18–25 Gy, as part of their treatment for ALL, are severely GH deficient now and should be considered for GH replacement. Changes in GH secretion evolve with time following irradiation-induced damage to the hypothalamic-pituitary axis; therefore long-term surveillance will be required in those remaining patients, in whom GH status is considered currently to be insufficient or even normal.Keywords
This publication has 28 references indexed in Scilit:
- High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhoodThe Journal of Pediatrics, 1995
- Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiationThe Journal of Pediatrics, 1993
- Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiencyThe Journal of Clinical Endocrinology & Metabolism, 1993
- An association between hypothalamic‐pituitary dysfunction and peripheral endocrine function in extreme obesityClinical Endocrinology, 1991
- Dose dependency of time of onset of radiation-induced growth hormone deficiencyThe Journal of Pediatrics, 1991
- The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone DeficiencyNew England Journal of Medicine, 1989
- GROWTH IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKAEMIAThe Lancet, 1988
- GROWTH FAILURE AND GROWTH-HORMONE DEFICIENCY AFTER TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKAEMIAThe Lancet, 1987
- Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemiaThe Journal of Pediatrics, 1984
- Normal growth despite abnormalities of growthhormone secretion in children treated for acute leukemiaThe Journal of Pediatrics, 1979